This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Amanda Haas
Business Development Manager, Nucleic Acid Solutions Division at Agilent Technologies
Speaker

Profile

Amanda Haas is a Business Development Manager at Agilent Technologies with over 20 years of experience in life sciences and biotechnology. She has been with Agilent for 4 years, growing gene editing therapeutic services, using market research, voice of the customer and collaborating with the development team. Amanda holds a B.S. degree in Chemistry from the University of Miami. She previously worked at Horizon Discovery, Dharmacon, and Thermo Fisher Scientific.


Agenda Sessions

  • Streamlining Development of Complex RNA Therapeutics: Manufacturing Coordination and Purification Techniques

    14:00